Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 21 Rectal Neoplasms 18 Colonic Neoplasms 18 Stomach Neoplasms 13 Ovarian Neoplasms 10 Neoplasms 5 Gastrointestinal Stromal Tumors 5 Carcinoma, Hepatocellular 5 Peritoneal Neoplasms 4 Endometrial Neoplasms 4 Carcinoma, Renal Cell 4 Uterine Cervical Neoplasms 3 Pancreatic Neoplasms 3 Liver Neoplasms 3 Kidney Neoplasms 3 Prostatic Neoplasms 2 Neoplastic Cells, Circulating 2 Fallopian Tube Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Esophageal Neoplasms 2 Carcinoma, Ovarian Epithelial 2 Breast Neoplasms 2 Venous Thrombosis 1 Uterine Neoplasms 1 Urinary Incontinence 1 Surgical Wound Infection 1 Sexual Dysfunction, Physiological 1 Robotic 1 Polycystic Ovary Syndrome 1 Pancreatic Neuroendocrine Tumors 1

Interventions

Sorafenib 5 Blood Specimen Collection 4 lenvatinib 3 sintilimab 2 pembrolizumab 2 ledipasvir, sofosbuvir drug combination 2 halofantrine 2 camrelizumab 2 atezolizumab 2 Liver Transplantation 2 Immunotherapy 2 Control Groups 2 Bevacizumab 2 Antibodies 2 veliparib 1 trifluridine tipiracil drug combination 1 trametinib 1 toripalimab 1 titanium silicide 1 tislelizumab 1 rubitecan 1 repotrectinib 1 pevonedistat 1 ozanimod 1 linifanib 1 genexol-PM 1 gadolinium ethoxybenzyl DTPA 1 fluorocholine 1 fisogatinib 1 ficlatuzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Liver Diseases × Laparoscopy × Clear all

NCT01567631 2016-02-01

LAHIGA

Southwest Hospital, China

Phase NA Unknown

Gastrointestinal

Liver Diseases, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡